Literature DB >> 2197848

Evaluation of vitamin A toxicity.

J N Hathcock1, D G Hattan, M Y Jenkins, J T McDonald, P R Sundaresan, V L Wilkening.   

Abstract

Toxicity has been associated with abuse of vitamin A supplements and with diets extremely high in preformed vitamin A. Consumption of 25,000-50,000 IU/d for periods of several months or more can produce multiple adverse effects. The lowest reported intakes causing toxicity have occurred in persons with liver function compromised by drugs, viral hepatitis, or protein-energy malnutrition. Certain drugs or other chemicals may markedly potentiate vitamin A toxicity in animals. Especially vulnerable groups include children, with adverse effects occurring with intakes as low as 1,500 IU.kg-1.d-1, and pregnant women, with birth defects being associated with maternal intakes as low as approximately 25,000 IU/d. The maternal dose threshold for birth defects cannot be identified from present data. An identifiable fraction of the population surveyed consumes vitamin A supplements at 25,000 IU/d and a few individuals consume much more. beta-Carotene is much less toxic than vitamin A.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2197848     DOI: 10.1093/ajcn/52.2.183

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  48 in total

Review 1.  Drug-induced congenital defects: strategies to reduce the incidence.

Authors:  M De Santis; B Carducci; A F Cavaliere; L De Santis; G Straface; A Caruso
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Transcription factor Smad3 is required for the inhibition of adipogenesis by retinoic acid.

Authors:  François Marchildon; Catherine St-Louis; Rahima Akter; Victoria Roodman; Nadine L Wiper-Bergeron
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

3.  High provitamin A carotenoid serum concentrations, elevated retinyl esters, and saturated retinol-binding protein in Zambian preschool children are consistent with the presence of high liver vitamin A stores.

Authors:  Stephanie Mondloch; Bryan M Gannon; Christopher R Davis; Justin Chileshe; Chisela Kaliwile; Cassim Masi; Luisa Rios-Avila; Jesse F Gregory; Sherry A Tanumihardjo
Journal:  Am J Clin Nutr       Date:  2015-07-15       Impact factor: 7.045

Review 4.  Vitamin supplementation therapy in the elderly.

Authors:  J E Thurman; A D Mooradian
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

5.  Therapeutic vitamin A doses increase the levels of markers of oxidative insult in substantia nigra and decrease locomotory and exploratory activity in rats after acute and chronic supplementation.

Authors:  Marcos Roberto de Oliveira; Roberta Bristot Silvestrin; Tadeu Mello e Souza; José Cláudio Fonseca Moreira
Journal:  Neurochem Res       Date:  2007-08-22       Impact factor: 3.996

Review 6.  Retinol (vitamin A) supplements in the elderly.

Authors:  B J Ward
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

7.  Hyperthermia, radiation carcinogenesis and the protective potential of vitamin A and N-acetylcysteine.

Authors:  P Sminia; A H van der Kracht; W M Frederiks; W Jansen
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

8.  Vitamin A and retinol intakes and the risk of fractures among participants of the Women's Health Initiative Observational Study.

Authors:  Graciela Caire-Juvera; Cheryl Ritenbaugh; Jean Wactawski-Wende; Linda G Snetselaar; Zhao Chen
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

9.  A comparison of the roles of peroxisome proliferator-activated receptor and retinoic acid receptor on CYP26 regulation.

Authors:  Suzanne Tay; Leslie Dickmann; Vaishali Dixit; Nina Isoherranen
Journal:  Mol Pharmacol       Date:  2009-11-02       Impact factor: 4.436

Review 10.  Dietary retinol: prevention or promotion of carcinogenesis in humans?

Authors:  S T Mayne; S Graham; T Z Zheng
Journal:  Cancer Causes Control       Date:  1991-11       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.